BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35852018)

  • 21. Prion disease pathogenesis in the absence of the commensal microbiota.
    Bradford BM; Tetlow L; Mabbott NA
    J Gen Virol; 2017 Jul; 98(7):1943-1952. PubMed ID: 28708055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling.
    Nuvolone M; Paolucci M; Sorce S; Kana V; Moos R; Matozaki T; Aguzzi A
    PLoS One; 2017; 12(5):e0177876. PubMed ID: 28545141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glial activation in prion diseases is selectively triggered by neuronal PrP
    Lakkaraju AKK; Sorce S; Senatore A; Nuvolone M; Guo J; Schwarz P; Moos R; Pelczar P; Aguzzi A
    Brain Pathol; 2022 Sep; 32(5):e13056. PubMed ID: 35178783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phagocytic Activities of Reactive Microglia and Astrocytes Associated with Prion Diseases Are Dysregulated in Opposite Directions.
    Sinha A; Kushwaha R; Molesworth K; Mychko O; Makarava N; Baskakov IV
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.
    Li B; Chen M; Aguzzi A; Zhu C
    J Mol Med (Berl); 2021 Jun; 99(6):877-887. PubMed ID: 33758958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the reactive states of astrocytes in prion diseases.
    Baskakov IV
    Prion; 2021 Dec; 15(1):87-93. PubMed ID: 34057026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
    Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
    Front Immunol; 2020; 11():579000. PubMed ID: 33162994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1β and neuronal toxicity.
    Hafner-Bratkovič I; Benčina M; Fitzgerald KA; Golenbock D; Jerala R
    Cell Mol Life Sci; 2012 Dec; 69(24):4215-28. PubMed ID: 22926439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced neuroinvasion by smaller, soluble prions.
    Bett C; Lawrence J; Kurt TD; Orru C; Aguilar-Calvo P; Kincaid AE; Surewicz WK; Caughey B; Wu C; Sigurdson CJ
    Acta Neuropathol Commun; 2017 Apr; 5(1):32. PubMed ID: 28431576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Temporospatial Characterization of the Glial Response to Prion Infection.
    Michael AV; Greenlee JJ; Harm TA; Moore SJ; Zhang M; Lind MS; Greenlee MHW; Smith JD
    Vet Pathol; 2020 Jan; 57(1):90-107. PubMed ID: 31331254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal activation of glial cells in the brains of prion protein-deficient mice ectopically expressing prion protein-like protein, PrPLP/Dpl.
    Atarashi R; Sakaguchi S; Shigematsu K; Arima K; Okimura N; Yamaguchi N; Li A; Kopacek J; Katamine S
    Mol Med; 2001 Dec; 7(12):803-9. PubMed ID: 11844868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt-Jakob disease.
    Andreoletti O; Levavasseur E; Uro-Coste E; Tabouret G; Sarradin P; Delisle MB; Berthon P; Salvayre R; Schelcher F; Negre-Salvayre A
    Neurobiol Dis; 2002 Dec; 11(3):386-93. PubMed ID: 12586548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid associated proteins in Alzheimer's and prion disease.
    Veerhuis R; Boshuizen RS; Familian A
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):235-48. PubMed ID: 15975027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
    Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
    Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.